- Exchange: NASDAQ GM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Snapshot for pSivida Corp (PSDV)
| Open: | 3.7900 | Day's Range: | 3.7600 - 3.9600 | Volume: | 630,344 |
|---|---|---|---|---|---|
| Previous Close: | 3.7200 | 52wk Range: | 1.1700 - 3.9600 | 1-Yr Rtn: | +100.00% |
Key Statistics for PSDV
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(06/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.4500 |
| Est. EPS (USD) (06/2013) | -0.4700 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 89.46 |
| Shares Outstanding (M) | 23.30 |
| 30 Day Average Volume | 172,760 |
| Price/Book (mrq) | 7.9584 |
| Price/Sale (ttm) | 36.3856 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 09/24/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for PSDV
Company Profile & Key Executives for PSDV
pSivida Corporation is a drug delivery company. The Company develops products utilizing its own technologies for targeted and controlled drug delivery. pSivida's products are mainly used in ophthalmology and oncology healthcare sectors.
| Paul AshtonPresident/CEO | Lori H FreedmanVP:Corp Affairs/Secy/Gen Cnsl |
| Leonard S RossVP:Finance | Brian LeedmanVP:Investor Relations |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
PSDV News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page